GPD1L and hepatocellular carcinoma: The aim of this study is to investigate the prognostic significance and molecular characteristics of GPD1L in HCC, including its correlation with clinical outcomes, its role in tumorigenesis and progression, and its potential as a predictive biomarker for treatment response.